跳至主要内容
临床试验/NCT01991366
NCT01991366撤回不适用

Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction?

Medstar Health Research Institute1 个研究点 分布在 1 个国家开始时间: 2013年10月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
All-cause mortality and composite or Q-wave myocardial infarction

研究概览

简要总结

The aim of this observational study is to evaluate the in hospital and 6 month outcomes of the use of Glycoprotein IIb/IIIa inhibitor eptifibatide as adjunctive therapy in patients undergoing primary Percutaneous Coronary Intervention for ST-elevation myocardial infarction in a large tertiary referral center.

It is hypothesized that Glycoprotein IIb/IIIa inhibitor use during primary Percutaneous Coronary Intervention for ST-elevation myocardial infarction/ acute myocardial infarction is superior to unfractionated heparin alone or bivalirudin alone. Additionally, after propensity matching this superiority remains.

详细描述

This is a retrospective, observational, data analysis of approximately 800 patients who underwent primary Percutaneous Coronary Intervention at our institution since September 2000. Patients will have either received eptifibatide pre-or during Percutaneous Coronary Intervention or have received no eptifibatide. Patients who received a thrombolytic prior to Percutaneous Coronary Intervention will be excluded.

This analysis is estimated to take 1-2 months.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Underwent Percutaneous Coronary Intervention at Washington Hospital Center since September 2000
  • Either received eptifibatide pre-or during PCI or have received no eptifibatide.

排除标准

  • Patients who received a thrombolytic prior to Percutaneous Coronary Intervention.

结局指标

主要结局

All-cause mortality and composite or Q-wave myocardial infarction

时间窗: Chart review 6 months after PCI

6-month rates of all-cause mortality and the composite of all-cause mortality or Q-wave myocardial infarction.

次要结局

  • TIMI major bleeding(During hospital stay; average stay is less than 48 hours)

研究者

发起方
Medstar Health Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验